-
PROVIDERS
New MRD Medicare Coverage for Select Indications*
*When coverage criteria are met. Additional criteria and exceptions for coverage may apply.
-
LIFE SCIENCES
Register now
UPCOMING WEBINARTranslating data into an actionable R&D strategy
-
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
Powering Discovery: Tempus Multimodal Database
Targeting discovery is an important frontier in the fight against pancreatic cancer. Take a look at this example of how Tempus Multimodal Database enabled a pharmaceutical company to more quickly identify pancreatic cancer subtypes’ molecular signatures.
-
02/12/2026Beyond the EHR: Building a reliable mortality endpoint for oncology research
Emilie Scherrer, Senior Director and Head of Outcomes Research, explains how Tempus’ validated, composite mortality endpoint overcomes data fragmentation to provide a trustworthy foundation for real-world evidence.
Read more -
02/05/2026Accelerating a phase 1 oncology trial: The TIME Network’s impact on patient enrollment
For life sciences companies, speed and precision are paramount. The ability to efficiently launch a Phase 1 trial and generate early clinical data is fundamental to long-term success. The Tempus TIME Trial Network provides the infrastructure to help achieve these goals.
Read more -
02/05/2026Building the engine to scale data abstraction through AI
Learn how Tempus’ AI engine, built on agentic architectures, transforms unstructured clinical text into analysis-ready real-world data. Tempus AI leaders detail the multi-layered system that ensures speed, scale, and fidelity.
Read more
Assess your cohort’s feasibility with our RWD
Submit your preliminary criteria, and our team will provide a tailored feasibility assessment to help accelerate your research goals.*